Moreover, the results indicated that the mRNA level of SHCBP1 was negatively associated with patients’ disease-free survival rate, and further analysis reveals that patients with high SHCBP1 expression tend to have more lymph node metastasis. The gene discussed is SHCBP1; the disease is metastatic malignant neoplasm in the lymph nodes.